Regulatory B cells in periodontal disease

牙周病中的调节性 B 细胞

基本信息

  • 批准号:
    9903616
  • 负责人:
  • 金额:
    $ 30.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-13 至 2021-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary. The objective of our parent R01 grant (DE025255) is to determine the mechanism of B10-mediated inhibition of inflammation and periodontal bone resorption in periodontal disease. So far, our data have demonstrated that promoting local B10 function is achievable and that antigen specificity is required for the local infiltration of B10 cells. We are currently investigating the immune regulatory components that relay the ultimate function of B10 activation, in the context of immune cell-cell interaction, and how changes in such interactions may affect disease outcome. Such information is important because it allow us to design optimal strategies to synergize immune regulatory function to restore health and minimize untoward side effects of immune activation/inhibition. However, we realized the challenge to achieve these goals due to the lack of required expertise and resources at our hands. To overcome such challenge, we will take advantage of the newly established collaboration between the PI and Dr. Corneliu Sima, Assistant Professor at Harvard School of Dental Medicine. Dr. Sima is an early stage Investigator (ESI) with expertise in monocyte/macrophage biology and has developed optimized intravital gingival microscopy assays for assessment of leukocyte recruitment and phenotype in periodontal disease. Together with the in vivo imaging system (IVIS), we will be able to detect and trace local interactions between B10 and macrophages in gingival tissues. Our hypothesis is that B10 activation promotes macrophage activation toward a regulatory/anti-inflammatory and pro-resolving phenotype, which contribute to the reduced inflammation and bone loss. To test this hypothesis, we will first determine the effect of activated B10 cells on Macrophage phenotype in vitro using a cell co-culture system (Aim 1). Then we will investigate the Macrophage phenotype switching and gingival inflammation after adoptive B10 transfer using IVIS and intravital microscopy (Aim 2). In summary, the points aligned with the goal of this FOA are the following: 1. This proposal is a collaboration with an ESI to explore novel mechanism of synergistic interaction between innate (Dr. Sima) and adaptive immunity (Dr. Han). 2. Extend our hypothesis and utilize techniques unavailable to PI of the parent R01, which is an important enhancement within the scope of the original Aims. 3. Take advantage of the cutting-edge cell imaging technologies with high sensitivity and resolution to fill the gap of precision imaging of oral lesions used in immunology research. 4. If successful, it will benefit both collaborative investigators for future R01 applications. 5. The collaborators in the proposal don't have any past record of collaboration. 6. No proposed salary allocation for PIs from this fund.
项目总结。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaozhe Han其他文献

Xiaozhe Han的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaozhe Han', 18)}}的其他基金

Impact of Diabetes hyperglycemia on peri-implantitis
糖尿病高血糖对种植体周围炎的影响
  • 批准号:
    10668057
  • 财政年份:
    2023
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulatory B cells in the amelioration of immune-mediated periodontal disease
调节性 B 细胞改善免疫介导的牙周病
  • 批准号:
    9274286
  • 财政年份:
    2015
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulatory B Cell in the Amelioration of Immune-Mediated Periodontal Disease
调节性 B 细胞改善免疫介导的牙周病
  • 批准号:
    10622334
  • 财政年份:
    2015
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulatory B cells in the amelioration of immune-mediated periodontal disease
调节性 B 细胞改善免疫介导的牙周病
  • 批准号:
    9105732
  • 财政年份:
    2015
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulatory B Cells in the Amelioration of Immune-Mediated Periodontal Disease
调节性 B 细胞改善免疫介导的牙周病
  • 批准号:
    10297736
  • 财政年份:
    2015
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulatory B Cell in the Amelioration of Immune-Mediated Periodontal Disease
调节性 B 细胞改善免疫介导的牙周病
  • 批准号:
    10605851
  • 财政年份:
    2015
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulatory B cells in the amelioration of immune-mediated periodontal disease
调节性 B 细胞改善免疫介导的牙周病
  • 批准号:
    8896097
  • 财政年份:
    2014
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulation of B-Cell Apoptosis by TLR Signaling in Periodontal Disease
牙周病中 TLR 信号转导对 B 细胞凋亡的调节
  • 批准号:
    8270446
  • 财政年份:
    2011
  • 资助金额:
    $ 30.85万
  • 项目类别:
Regulation of B-Cell Apoptosis by TLR Signaling in Periodontal Disease
牙周病中 TLR 信号转导对 B 细胞凋亡的调节
  • 批准号:
    8093847
  • 财政年份:
    2011
  • 资助金额:
    $ 30.85万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 30.85万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 30.85万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 30.85万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 30.85万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 30.85万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 30.85万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 30.85万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 30.85万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 30.85万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 30.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了